Does the race or gender of hepatitis C infected patients influence physicians' assessment of hepatitis A and hepatitis B serologic status

Southern Medical Journal

Volumn 100, Issue 7, 2007, Pages 683-685

  Ramsay, David B ^a,b   Friedman, Mark ^a   Borum, Marie L ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Gender issues; Hepatitis A virus; Hepatitis B virus; Hepatitis C virus; Immunization; Race

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PHYSICIAN; RACE DIFFERENCE; SEROLOGY; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ACADEMIC MEDICAL CENTERS; AFRICAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEPATITIS A; HEPATITIS B; HEPATITIS C, CHRONIC; HUMANS; MALE; MEDICAL AUDIT; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SEROLOGIC TESTS; SEX FACTORS;

EID: 34447301495     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318063ecc5     Document Type: Article

References (18)

1. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consensus and State-of-the Science Statements 2002;19:1-52.
2. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51:1-78.
3. Viral hepatitis Consensus Panel. Promoting prevention of viral hepatitis in the African American community. J Natl Med Assoc 2003;95(4 Suppl): 49S-56S.
4. Poland GA. Evaluating existing recommendations for hepatitis A and B vaccination. Am J Med 2005;118(Suppl 10A):16S-20S.
5. Lau DT, Hewlett AT. Screening for hepatitis A and B antibodies in patients with chronic liver disease. Am J Med 2005;118(Suppl):28S-33S.
6. Strader DB. Hepatitis C virus among African American persons. Current Hepatitis Reports 2004;3:129-135.
7. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998;47:1-39.
8. Howell C, Jeffers L, Hoofnagle J. Hepatitis C in African Americans: summary of a workshop. Gastroenterology 2000;119:1385-1396.
9. Raimondo G, Brunetto MR, Pontisso P, et al. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients. Hepatology 2006;43:100-107.
10. Wong V, Wreghitt TG, Alexander GJ. Prospective study of hepatitis B vaccination in patients with chronic hepatitis C. BMJ 1996;312:1336-1337.
11. Chlabicz S, Grzeszczuk A. Hepatitis B virus vaccine for patients with hepatitis C virus infection. Infection 2000;28:341-345.
12. Idilman R, De MN, Colantoni A, et al. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C. Am J Gastroenterol 2002;97:435-439.
13. Vento S, Garofano T, Renzini C, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998;338:286-290.
14. Jacobs R, Koff R, Meyerhoff A. The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A. Am J Gastroenterol 2002;97:427-434.
15. Rawls RA, Vega KJ. Viral hepatitis in minority America. J Clin Gastroenterol 2005;39:144-151.
16. Sherman KE, Rouster SD, Chung RT, et al. Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis 2002;34:831-837.
17. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents: DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents. 2004 May;1-120.
18. Aberg J, Gallant J, Anderson J, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2004;39:609-629.